Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Forensic Science, Medicine and Pathology
Erschienen in:

03.06.2020 | Case Report

Sudden death of a young adult with coronary artery vasculitis, coronary aneurysms, parvovirus B19 infection and Kawasaki disease

verfasst von: Stefan Flossdorf, Karl Heinz Schiwy-Bochat, Daniela Teifel, Jochen W. U. Fries, Markus A. Rothschild

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

We present a case of a 20-year-old man who suffered from Kawasaki disease (KD) associated with a florid parvovirus infection, and who died suddenly from thrombotic occlusion of the coronary arteries. The autopsy revealed several aneurysms of the coronary arteries, a chronic vasculitis and a myofibroblast proliferation leading to focal luminal narrowing. The inflammatory response as well as the detection of the viral particles by PCR in blood and in the lesional tissue demonstrated a possible cause by Parvovirus infection. The expression of endoglin on endothelial cells of neoangiogenesis indicates the involvement of the TGF-beta pathway, necessary for maintaining chronic inflammation. In addition, a possible connection between the intake of methylphenidate, arteritis and a possible pre-existing heart disease must be discussed. Furthermore, KD must also be considered as a cause of sudden death in the adult population.
Literatur
1.
Del Principe D, Pietraforte D, Gambardella L, Marchesi A, Tarissi de Jacobis I, Villani A, et al. Pathogenetic determinants in Kawasaki disease: the haematological point of view. J Cell Mol Med. 2017;21:632–9.PubMedPubMedCentral
2.
Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004;364:533–44.PubMed
3.
Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25:239–45.PubMed
4.
Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22:79–85.PubMedPubMedCentral
5.
Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H. Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet. 1992;340:1127–9.PubMed
6.
Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One. 2012;7:e38998.PubMedPubMedCentral
7.
Rowley AH. The complexities of the diagnosis and management of Kawasaki disease. Infect Dis Clin N Am. 2015;29:525–37.
8.
Furukawa S, Matsubara T, Yabuta K. Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Arch Dis Child. 1992;67:706–8.PubMedPubMedCentral
9.
Nigro G, Zerbini M, Krzysztofiak A, Gentilomi G, Porcaro MA, Mango T, et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet. 1994;343:1260–1.PubMed
10.
Holm JM, Hansen LK, Oxhoj H. Kawasaki disease associated with parvovirus B19 infection. Eur J Pediatr. 1995;154:633–4.PubMed
11.
Shike H, Shimizu C, Kanegaye JT, Foley JL, Schnurr DP, Wold LJ, et al. Adenovirus, adeno-associated virus and Kawasaki disease. Pediatr Infect Dis J. 2005;24:1011–4.PubMed
12.
Chang LY, Lu CY, Shao PL, Lee PI, Lin MT, Fan TY, et al. Viral infections associated with Kawasaki disease. J Formos Med Assoc. 2014;113:148–54.PubMedPubMedCentral
13.
Giray T, Bicer S, Kucuk O, Col D, Yalvac Z, Gurol Y, et al. Four cases with Kawasaki disease and viral infection: aetiology or association. Infez Med. 2016;24:340–4.PubMed
14.
Bajolle F, Meritet JF, Rozenberg F, Chalumeau M, Bonnet D, Gendrel D, et al. Markers of a recent bocavirus infection in children with Kawasaki disease: "a year prospective study". Pathol Biol (Paris). 2014;62:365–8.
15.
Shirato K, Imada Y, Kawase M, Nakagaki K, Matsuyama S, Taguchi F. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease. J Med Virol. 2014;86:2146–53.PubMedPubMedCentral
16.
Rigante D, Cantarini L, Piastra M, Angelone DF, Valentini P, Pardeo M, et al. Kawasaki syndrome and concurrent Coxsackie virus B3 infection. Rheumatol Int. 2012;32:4037–40.PubMed
17.
Usta Guc B, Cengiz N, Yildirim SV, Uslu Y. Cytomegalovirus infection in a patient with atypical Kawasaki disease. Rheumatol Int. 2008;28:387–9.PubMed
18.
Kikuta H, Matsumoto S, Osato T. Kawasaki disease and Epstein-Barr virus. Acta Paediatr Jpn. 1991;33:765–70.PubMed
19.
Culora GA, Moore IE. Kawasaki disease, Epstein-Barr virus and coronary artery aneurysms. J Clin Pathol. 1997;50:161–3.PubMedPubMedCentral
20.
Turkay S, Odemis E, Karadag A. Kawasaki disease onset during concomitant infections with varicella zoster and Epstein-Barr virus. J Natl Med Assoc. 2006;98:1350–2.PubMedPubMedCentral
21.
Shingadia D, Bose A, Booy R. Could a herpesvirus be the cause of Kawasaki disease? Lancet Infect Dis. 2002;2:310–3.PubMed
22.
Huang X, Huang P, Zhang L, Xie X, Xia S, Gong F, et al. Influenza infection and Kawasaki disease. Rev Soc Bras Med Trop. 2015;48:243–8.PubMed
23.
Johnson D, Azimi P. Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection. Pediatr Infect Dis. 1985;4:100.PubMed
24.
Cohen BJ. Human parvovirus B19 infection in Kawasaki disease. Lancet. 1994;344:59.PubMed
25.
Muniain-Ezcurra M, Bueno-Mariscal C, Rodriguez-Bano J, Dominguez-Castellano A, Balonga-Tomas B, Rios-Villegas MJ, et al. Kawasaki disease and parvovirus B19 infection in an adult HIV-1-infected patient. Clin Microbiol Infect. 1998;4:609–10.PubMed
26.
Turnier JL, Anderson MS, Heizer HR, Jone PN, Glode MP, Dominguez SR. Concurrent respiratory viruses and Kawasaki disease. Pediatrics. 2015;136:e609–14.PubMed
27.
Hamada H, Suzuki H, Abe J, Suzuki Y, Suenaga T, Takeuchi T, et al. Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease. Cytokine. 2012;60:681–5.PubMed
28.
Li X, Deroide N, Mallat Z. The role of the inflammasome in cardiovascular diseases. J Mol Med (Berl). 2014;92:307–19.
29.
Takahashi K, Oharaseki T, Yokouchi Y. Update on etio and immunopathogenesis of Kawasaki disease. Curr Opin Rheumatol. 2014;26:31–6.PubMed
30.
Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A, Burns JC. The role of TGF-beta and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol. 2013;44:189–98.PubMed
31.
Altomonte M, Montagner R, Fonsatti E, Colizzi F, Cattarossi I, Brasoveanu LI, et al. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma. Br J Cancer. 1996;74:1586–91.PubMedPubMedCentral
32.
Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem. 1999;274:584–94.PubMed
33.
Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem. 2002;277:29197–209.PubMed
34.
Sanz-Rodriguez F, Guerrero-Esteo M, Botella LM, Banville D, Vary CP, Bernabeu C. Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J Biol Chem. 2004;279:32858–68.PubMed
35.
Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol. 2001;22:138–42.PubMed
36.
Rozin L, Koehler SA, Shakir A, Ladham S, Wecht CH. Kawasaki disease: a review of pathologic features of stage IV disease and two cases of sudden death among asymptotic young adults. Am J Forensic Med Pathol. 2003;24:45–50.PubMed
37.
Daniels LB, Gordon JB, Burns JC. Kawasaki disease: late cardiovascular sequelae. Curr Opin Cardiol. 2012;27:572–7.PubMed
38.
Ohni S, Goto S, Nakamura H, Yamada T, Taira M, Sakurai I. Adult multiple coronary aneurysms of Kawasaki's disease's sequelae; two autopsy cases. Rinsho Byori. 1998;46:177–81.PubMed
39.
Fineschi V, Paglicci Reattelli L, Baroldi G. Coronary artery aneurysms in a young adult: a case of sudden death. A late sequelae of Kawasaki disease? Int J Legal Med. 1999;112:120–3.PubMed
40.
Bartoloni G, Salvatrice DM, Carlo R. Sudden death in a 21-year-old man caused by thrombosed coronary aneurysm: late sequelae or a very late onset of Kawasaki disease? Cardiovasc Pathol. 2002;11:318–21.PubMed
41.
Atik E. Case 1/2012: 55-year-old male with multiple coronary artery aneurysms due to Kawasaki disease. Arq Bras Cardiol. 2012;98:e1–2.PubMed
42.
Kilic ID, Di Mario C. Atherosclerotic changes in coronary aneurysms post-Kawasaki disease: in vivo demonstration with near-infrared spectroscopy and intravascular ultrasound. Eur Heart J. 2014;35:2506.PubMed
43.
44.
Baumeister TB, Wickenbrock I, Perings CA. STEMI secondary to coronary vasospasm: possible adverse event of methylphenidate in a 21-year-old man with ADHD. Drug Saf Case Rep. 2016;3:10.PubMedPubMedCentral
Metadaten
Titel
Sudden death of a young adult with coronary artery vasculitis, coronary aneurysms, parvovirus B19 infection and Kawasaki disease
verfasst von
Stefan Flossdorf
Karl Heinz Schiwy-Bochat
Daniela Teifel
Jochen W. U. Fries
Markus A. Rothschild
Publikationsdatum
03.06.2020
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 3/2020
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-020-00263-y

Weitere Artikel der Ausgabe 3/2020

Death scene investigation and autopsy proceedings in identifying the victims of the terror attack on the Breitscheidplatz in Berlin 19th December 2016

  • Open Access
  • Case Report

A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19

  • Zur Zeit gratis
  • COVID-19
  • Technical Report

Suicidal tandem bullets to the heart with subsequent embolization – a case report

  • Case Report

The manifestations of acid attacks (vitriolage or vitriolism)

  • Editorial

King Richard III revisited

  • Lessons from the Museum

Weight-of-evidence for DNA identification of missing persons and human remains using CODIS

  • Original Article

Neu im Fachgebiet Pathologie

Pathologie der Milz

Nach einer Beschreibung der Milzanatomie und Darstellung der diagnostisch wichtigsten immunhistochemischen Färbungen zur Identifizierung der normalen Milzkompartimente werden am Beispiel eines nordafrikanischen Patienten mit rezentem …

Molekular definierte Nierenzellkarzinome 2025

Im Zuge der Überarbeitung der WHO-Klassifikation im Jahr 2022 konnten für mehrere Nierenzellkarzinome (NZK), die sich zuvor nicht eindeutig den bis dahin definierten Tumortypen zuordnen ließen, jedoch gemeinsame morphologische und molekulare …

Wichtige Änderungen in der WHO-Klassifikation der Hodentumoren 2022

In der 5. Auflage der „WHO-Klassifikation der Tumoren der ableitenden Harnwege und des männlichen Genitaltrakts“ sind bedeutende Anpassungen an den bisherigen Klassifikationen vorgenommen worden. Diese betreffen bei den Keimzelltumoren des Hodens …

DNA mixture deconvolution using fully continuous models EuroForMix and EFMrep

  • Open Access
  • Originalien

Mixture deconvolution is a powerful tool for inferring individual DNA profiles from DNA mixtures for subsequent transmission to a database or database queries. To carry out deconvolution, a mixed trace can be interpreted either manually by an …